Researchers link stress and pancreatic cancer in new paper

Pancreatic cancer is a deadly disease with increased incidences in the recent years. According to NDSU researchers, epidemiological data show chronic stress in a negative social and psychological state such as depression might serve as a risk factor for cancer development and progression. However, the underlying biological mechanisms are not well understood. 

Erxi Wu, assistant professor of pharmaceutical sciences, and Fengfei Wang, research associate of , co-wrote the article, "B2-AR-HIF-1a: a Novel Regulatory Axis for Stress-Induced Pancreatic Tumor Growth and Angiogenesis," which will be published by Current Molecular Medicine

"It is noted that in Asian countries, like China, doctors usually do not tell patients they have cancer directly after a diagnosis because the doctor is concerned the stress caused by knowing they have the deadly disease may worsen the cancer status, but the scientific evidence is not known so far," said Wu, the paper's senior author. 

The authors created a new stress model system to determine the effects of on pancreatic . They show chronic stress not only results in mice gaining depression behavior due to an elevated level of epinephrine, but also induces cancer progression. They further demonstrate that the pancreatic and progression induced by chronic stress was blocked by a B2-AR inhibitor ICI118 551 or a HIF-1a inhibitor 2-Methoxyestradiol and that the chronic stress up-regulates the expression of MMP-2, MMP-9, and VEGF via a HIF-1a-dependent B-AR signaling pathway. 

"Our data suggest that B2-AR-HIF-1a axis regulates stress-induced pancreatic and angiogenesis. This study may have a therapeutic or preventive potential for the patients with pancreatic cancer who are especially subject to psychosocial stress," Wu said. 

The paper was co-written with Qingyong Ma lab at Xi'an Jiaotong University, China. "Collaborating with Dr. Ma, we together would like to find better cancer therapeutics and elucidate the mechanisms of the targeted therapy for pancreatic carcinoma," Wu said. 

add to favorites email to friend print save as pdf

Related Stories

Pharmaceutical sciences researchers to publish paper

Nov 15, 2011

Erxi Wu, assistant professor of pharmaceutical sciences, and Shuang Zhou, doctoral student of pharmaceutical sciences in Wu’s lab, co-wrote the article, "High glucose promotes pancreatic cancer cell proliferation via ...

Researchers to publish paper in Molecular Cancer journal

Dec 07, 2011

(Medical Xpress) -- Erxi Wu, assistant professor of pharmaceutical sciences, and Fengfei Wang, research associate in pharmaceutical sciences, co-wrote the article, "β2-adrenoceptor blockage induces G1/S phase arrest ...

Nerve growth factors elevated in pancreatic cancer model

Jun 19, 2012

Severe pain is a major symptom of pancreatic cancer. The results of a new study show that four different factors involved in the growth and maintenance of nerves are elevated in a mouse model of pancreatic cancer. This is ...

Recommended for you

Generation of tanners see spike in deadly melanoma

2 hours ago

(AP)—Stop sunbathing and using indoor tanning beds, the acting U.S. surgeon general warned in a report released Tuesday that cites an alarming 200 percent jump in deadly melanoma cases since 1973.

Penn team makes cancer glow to improve surgical outcomes

2 hours ago

The best way to cure most cases of cancer is to surgically remove the tumor. The Achilles heel of this approach, however, is that the surgeon may fail to extract the entire tumor, leading to a local recurrence.

Cancer: Tumors absorb sugar for mobility

15 hours ago

Cancer cells are gluttons. We have long known that they monopolize large amounts of sugar. More recently, it became clear that some tumor cells are also characterized by a series of features such as mobility or unlikeliness ...

User comments